These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 12915670

  • 41. Bone metabolism markers and bone mass in healthy pubertal boys and girls.
    van Coeverden SC, Netelenbos JC, de Ridder CM, Roos JC, Popp-Snijders C, Delemarre-van de Waal HA.
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):107-16. PubMed ID: 12100078
    [Abstract] [Full Text] [Related]

  • 42. Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility.
    Kacker R, Conners W, Zade J, Morgentaler A.
    J Urol; 2014 Apr; 191(4):1072-6. PubMed ID: 24161998
    [Abstract] [Full Text] [Related]

  • 43. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared MF, Gharib A.
    Horm Res Paediatr; 2010 Apr; 74(6):428-35. PubMed ID: 20628237
    [Abstract] [Full Text] [Related]

  • 44. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
    Brufsky A, Bundred N, Coleman R, Lambert-Falls R, Mena R, Hadji P, Jin L, Schenk N, Ericson S, Perez EA, Z-FAST and ZO-FAST Study Groups.
    Oncologist; 2008 May; 13(5):503-14. PubMed ID: 18515735
    [Abstract] [Full Text] [Related]

  • 45. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats.
    Goss PE, Qi S, Cheung AM, Hu H, Mendes M, Pritzker KP.
    Clin Cancer Res; 2004 Sep 01; 10(17):5717-23. PubMed ID: 15355898
    [Abstract] [Full Text] [Related]

  • 46. A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
    McCaig FM, Renshaw L, Williams L, Young O, Murray J, Macaskill EJ, McHugh M, Hannon R, Dixon JM.
    Breast Cancer Res Treat; 2010 Feb 01; 119(3):643-51. PubMed ID: 19941160
    [Abstract] [Full Text] [Related]

  • 47. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M, Wickman S, Dunkel L.
    Clin Endocrinol (Oxf); 2006 May 01; 64(5):510-3. PubMed ID: 16649968
    [Abstract] [Full Text] [Related]

  • 48. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Kyvernitakis I, Albert US, Kalder M, Winarno AS, Hars O, Hadji P.
    Climacteric; 2015 Feb 01; 18(1):63-8. PubMed ID: 24884402
    [Abstract] [Full Text] [Related]

  • 49. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R, Gunczler P, Esaa S, Weisinger JR.
    Clin Endocrinol (Oxf); 2002 Dec 01; 57(6):725-30. PubMed ID: 12460321
    [Abstract] [Full Text] [Related]

  • 50. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study.
    Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS.
    J Clin Endocrinol Metab; 2002 Jun 01; 87(6):2798-808. PubMed ID: 12050253
    [Abstract] [Full Text] [Related]

  • 51. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
    Meier C, Liu PY, Ly LP, de Winter-Modzelewski J, Jimenez M, Handelsman DJ, Seibel MJ.
    J Clin Endocrinol Metab; 2004 Jun 01; 89(6):3033-41. PubMed ID: 15181095
    [Abstract] [Full Text] [Related]

  • 52. A 1-year prospective study on the relationship between physical activity, markers of bone metabolism, and bone acquisition in peripubertal girls.
    Lehtonen-Veromaa M, Möttönen T, Irjala K, Nuotio I, Leino A, Viikari J.
    J Clin Endocrinol Metab; 2000 Oct 01; 85(10):3726-32. PubMed ID: 11061531
    [Abstract] [Full Text] [Related]

  • 53. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.
    Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE.
    Breast Cancer Res Treat; 2010 Apr 01; 120(2):427-35. PubMed ID: 19967558
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
    Van Pottelbergh I, Goemaere S, Kaufman JM.
    J Clin Endocrinol Metab; 2003 Jul 01; 88(7):3075-81. PubMed ID: 12843146
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

  • 58. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P.
    Neuro Endocrinol Lett; 2007 Oct 01; 28(5):621-8. PubMed ID: 17984937
    [Abstract] [Full Text] [Related]

  • 59. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Nieminen M.
    Osteoporos Int; 1999 Oct 01; 10(2):128-36. PubMed ID: 10501793
    [Abstract] [Full Text] [Related]

  • 60. Bone mineral density and markers of bone turnover in boys with constitutional delay of growth and puberty.
    Krupa B, Miazgowski T.
    J Clin Endocrinol Metab; 2005 May 01; 90(5):2828-30. PubMed ID: 15687323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.